An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy
- Author
- TISEO, Marcello1 ; GRIDELLI, Cesare2 ; BELVEDERE, Ornella11 12 ; VALENTINO, Brunello13 ; BEARZ, Alessandra14 ; VENTURINO, Paola15 ; ARDIZZONI, Andrea1 ; CASCINU, Stefano3 ; CRINO, Lucio4 ; PIANTEDOSI, Franco Vito5 ; GROSSI, Francesco6 ; BRANDES, Alba A7 ; LABIANCA, Roberto8 ; SIENA, Salvatore9 ; AMOROSO, Domenico10
[1] Oncologia Medico, Azienda Ospedaliero-Universitaria, Parma, Italy
[2] Oncologia Medico, Azienda Ospedaliera Moscati, Avellino, Italy
[3] Clinica Oncotogica, Ospedale Umberto I, Ancona, Italy
[4] Oncologia Medico, Policlinico Monteluce, Perugia, Italy
[5] Preumologia Oncologica I, Azienda Ospedaliera Monaldi, Napoli, Italy
[6] Oncologia Medica A, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
[7] Oncologia Medico, Ospedale Bellaria, Bologna, Italy
[8] Oncologia Medico, Ospedali Riuniti, Bergamo, Italy
[9] Oncologia Medico Falck, Ospedale Niguarda Ca' Granda, Milano, Italy
[10] Oncologia Medica, Ospedale Versilia-lstituto Toscano Tumori, Lido di Camaiore, Italy
[11] Oncologia Medica, Azienda Ospedaliero-Universitaria Santa Maria delta Misericordia, Udine, Italy
[12] Leeds Institute of Molecular Medicine, University of Leeds, United Kingdom
[13] Pneumologia Oncologica II, Azienda Ospedaliera Monaldi, Napoli, Italy
[14] Oncologia Medica A, Centro di Riferimento Oncologico, Aviano, Italy
[15] Medical Affairs, Roche Spa, Milano, Italy - Source
Lung cancer. 2009, Vol 64, Num 2, pp 199-206, 8 p ; ref : 16 ref
- CODEN
- LUCAE5
- ISSN
- 0169-5002
- Scientific domain
- Medical oncology; Pneumology
- Publisher
- Elsevier, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Advanced NSCLC Erlotinib Expanded access program (EAP)
- Keyword (fr)
- Accessibilité Cancérologie Carcinome non petite cellule bronchopulmonaire Carcinome non petite cellule Erlotinib Expansion Homme Pathologie de l'appareil respiratoire Pneumologie Programme Stade avancé Italie Cancer Pathologie des bronches Pathologie des poumons Tumeur maligne Europe
- Keyword (en)
- Accessibility Cancerology non-small cell lung carcinoma Non small cell carcinoma Erlotinib Expansion Human Respiratory disease Pneumology Program Advanced stage Italy Cancer Bronchus disease Lung disease Malignant tumor Europe
- Keyword (es)
- Accesibilidad Cancerología Carcinoma no pequeňa célula bronchopulmonar Carcinoma no pequeña célula Erlotinib Expansión Hombre Aparato respiratorio patología Neumología Programa Estadio avanzado Italia Cáncer Bronquio patología Pulmón patología Tumor maligno Europa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum
- Discipline
- Pulmonology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21399355
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.lungcan.2008.09.001 
https://dx.doi.org/10.1016/j.lungcan.2008.09.001
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2008.09.001\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy\";s:9:\"\u0000*\u0000jtitle\";s:11:\"Lung cancer\";s:9:\"\u0000*\u0000stitle\";s:11:\"Lung cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"64\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"199\";s:8:\"\u0000*\u0000epage\";s:3:\"206\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0169-5002\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"TISEO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Marcello\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:16:\"GRIDELLI, Cesare\";i:1;s:18:\"BELVEDERE, Ornella\";i:2;s:19:\"VALENTINO, Brunello\";i:3;s:17:\"BEARZ, Alessandra\";i:4;s:16:\"VENTURINO, Paola\";i:5;s:17:\"ARDIZZONI, Andrea\";i:6;s:16:\"CASCINU, Stefano\";i:7;s:12:\"CRINO, Lucio\";i:8;s:23:\"PIANTEDOSI, Franco Vito\";i:9;s:17:\"GROSSI, Francesco\";i:10;s:15:\"BRANDES, Alba A\";i:11;s:17:\"LABIANCA, Roberto\";i:12;s:16:\"SIENA, Salvatore\";i:13;s:17:\"AMOROSO, Domenico\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LUCAE5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2008.09.001\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy\";s:9:\"\u0000*\u0000jtitle\";s:11:\"Lung cancer\";s:9:\"\u0000*\u0000stitle\";s:11:\"Lung cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"64\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"199\";s:8:\"\u0000*\u0000epage\";s:3:\"206\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0169-5002\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"TISEO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Marcello\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:16:\"GRIDELLI, Cesare\";i:1;s:18:\"BELVEDERE, Ornella\";i:2;s:19:\"VALENTINO, Brunello\";i:3;s:17:\"BEARZ, Alessandra\";i:4;s:16:\"VENTURINO, Paola\";i:5;s:17:\"ARDIZZONI, Andrea\";i:6;s:16:\"CASCINU, Stefano\";i:7;s:12:\"CRINO, Lucio\";i:8;s:23:\"PIANTEDOSI, Franco Vito\";i:9;s:17:\"GROSSI, Francesco\";i:10;s:15:\"BRANDES, Alba A\";i:11;s:17:\"LABIANCA, Roberto\";i:12;s:16:\"SIENA, Salvatore\";i:13;s:17:\"AMOROSO, Domenico\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LUCAE5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2008.09.001\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2008.09.001\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy\";s:9:\"\u0000*\u0000jtitle\";s:11:\"Lung cancer\";s:9:\"\u0000*\u0000stitle\";s:11:\"Lung cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"64\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"199\";s:8:\"\u0000*\u0000epage\";s:3:\"206\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0169-5002\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"TISEO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Marcello\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:16:\"GRIDELLI, Cesare\";i:1;s:18:\"BELVEDERE, Ornella\";i:2;s:19:\"VALENTINO, Brunello\";i:3;s:17:\"BEARZ, Alessandra\";i:4;s:16:\"VENTURINO, Paola\";i:5;s:17:\"ARDIZZONI, Andrea\";i:6;s:16:\"CASCINU, Stefano\";i:7;s:12:\"CRINO, Lucio\";i:8;s:23:\"PIANTEDOSI, Franco Vito\";i:9;s:17:\"GROSSI, Francesco\";i:10;s:15:\"BRANDES, Alba A\";i:11;s:17:\"LABIANCA, Roberto\";i:12;s:16:\"SIENA, Salvatore\";i:13;s:17:\"AMOROSO, Domenico\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LUCAE5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2008.09.001\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy\";s:9:\"\u0000*\u0000jtitle\";s:11:\"Lung cancer\";s:9:\"\u0000*\u0000stitle\";s:11:\"Lung cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"64\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"199\";s:8:\"\u0000*\u0000epage\";s:3:\"206\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0169-5002\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"TISEO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Marcello\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:16:\"GRIDELLI, Cesare\";i:1;s:18:\"BELVEDERE, Ornella\";i:2;s:19:\"VALENTINO, Brunello\";i:3;s:17:\"BEARZ, Alessandra\";i:4;s:16:\"VENTURINO, Paola\";i:5;s:17:\"ARDIZZONI, Andrea\";i:6;s:16:\"CASCINU, Stefano\";i:7;s:12:\"CRINO, Lucio\";i:8;s:23:\"PIANTEDOSI, Franco Vito\";i:9;s:17:\"GROSSI, Francesco\";i:10;s:15:\"BRANDES, Alba A\";i:11;s:17:\"LABIANCA, Roberto\";i:12;s:16:\"SIENA, Salvatore\";i:13;s:17:\"AMOROSO, Domenico\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LUCAE5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2008.09.001\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy\";s:9:\"\u0000*\u0000jtitle\";s:11:\"Lung cancer\";s:9:\"\u0000*\u0000stitle\";s:11:\"Lung cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"64\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"199\";s:8:\"\u0000*\u0000epage\";s:3:\"206\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0169-5002\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"TISEO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Marcello\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:16:\"GRIDELLI, Cesare\";i:1;s:18:\"BELVEDERE, Ornella\";i:2;s:19:\"VALENTINO, Brunello\";i:3;s:17:\"BEARZ, Alessandra\";i:4;s:16:\"VENTURINO, Paola\";i:5;s:17:\"ARDIZZONI, Andrea\";i:6;s:16:\"CASCINU, Stefano\";i:7;s:12:\"CRINO, Lucio\";i:8;s:23:\"PIANTEDOSI, Franco Vito\";i:9;s:17:\"GROSSI, Francesco\";i:10;s:15:\"BRANDES, Alba A\";i:11;s:17:\"LABIANCA, Roberto\";i:12;s:16:\"SIENA, Salvatore\";i:13;s:17:\"AMOROSO, Domenico\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LUCAE5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from Italy\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
